Background. The aim of our experimental work was to assess the impact and morphological changes that arise during different thawing protocols on human aortic valve (AV) leaflets resected from cryopreserved aortic root allografts (CARAs).
Introduction
The first allograft transplants in cardiac surgery were freshly harvested aortic valves (AVs). The first fresh AV allograft transplant was performed by Murray in 1956. 1 Despite the imperfect hemodynamic outcome of the operation, the allograft performance was outstanding, with perfect leaflet function. Other early experimental and clinical trials, such as Heimbecker, Lam et al. and Kerwin et al., supported the superior properties of fresh AV allografts. [2] [3] [4] Nevertheless, the first successful operation with a patient surviving the fresh AV allograft transplant was performed by Ross in 1962, based on Brewin's experimental work. 5, 6 Many cardiac centers started to implement cryopreservation of fresh AV allografts due to the shortage of donors. Cryopreservation of AVs led to a significant decrease of allograft durability, and between the 1960s and the early 1970s this led almost to the abandonment of these types of procedures. 7 This was primarily due to irreversible damage to cell viability and loss of the structural integrity caused by thawing, resulting in the loss of allograft toughness and elastic properties. [8] [9] [10] Technical advances in tissue handling led to the reintroduction of allograft transplants back into use in cardiac surgery. 11 To date, there have been no recommended guidelines for cryopreservation and subsequent thawing of cryopreserved allografts that would eliminate damage to the cellular structures.
Material and methods

Allograft harvest and characteristics
All the allografts were harvested in the operation theater from patients that were organ donors and were pronounced "clinically dead" in compliance with the transplant laws of the Czech Republic.
Basic allograft characteristics for thawing protocol 1 (thawing at room temperature of 23°C) are summarized in Table 1 . Basic allograft characteristics for thawing protocol 2 (thawing in a water bath at 37°C) are summarized in Table 2 .
Allograft processing cryopreservation protocol
All human aortic roots (ARA) underwent an initial decontamination according to the standard protocol of the tissue bank. Afterward, all allografts were stored in an antibiotic cocktail comprised of Cefuroxime 0.2 mg/mL + Piperacillin 0.2 mg/mL + Netilmicin 0.1 mg/mL + Fluconazole 0.1 mg/mL in the tissue culture nutrient medium E 199 for 24 h at 37°C (Altimed Pharmaceutical, Mississauga, Canada). Subsequently, all ARA were moved into a cryoprotectant solution in a sterile laminar flow cabinet; they were packed using a double layer technique (sealed in Gambro Hemofreeze bags; NPBI BV; Gambro, Utrecht, the Netherlands). The cryoprotectant used was 10% dimethyl sulfoxide in the nutritional source for cell culture E 199. All ARA were then cooled at a controlled rate of -1°C/min from 10°C to -60°C, and next rapidly cooled and stored in cryo-containers with a liquid phase of liquid nitrogen at -196°C.
Thawing protocols
Experimental work was based on investigating 12 cryopreserved aortic root allografts (CARAs). They were randomly divided into 2 groups, each group consisting of 6 samples. All allografts were thawed in their original packaging (packed using double layer technique and immersed in 10% dimethyl sulfoxide). Two thawing protocols were tested:
-protocol 1: 6 human CARAs thawed at room temperature of 23°C; thawing times were as follows: min 2 h 49 min, max 4 h 5 min (median: 3 h 19 min); -protocol 2: 6 human CARAs were placed directly into a water bath at 37°C; thawing times were as follows: min 26 min, max 41 min (median: 32 min). After all the CARAs were thawed, non-coronary AV leaflets were sampled from each specimen and fixated in a 4% formaldehyde solution before they were sent for morphological analysis. The time variability in both thawing protocols was given by different allografts sizes (Tables 1,2) , as well as different amounts of cryoprotectant used for each allograft during the cryopreservation process. 
Microscopic slide preparation
After the thawing protocols were completed, non-coronary AV leaflets were resected and fixed in Baker's solution. Each sample was divided into 5-10 mm subsamples. In order to prevent artificial mechanical damage to the cellular structures, no mechanical stretching of the samples was performed. All samples were washed in distilled water for 5 min, and dehydrated in a graded ethanol series (70%, 85%, 95%, and 100%) for 5 min at each level. The tissue samples were then immersed in 100% hexamethyldisilazane (HMDS) (CAS No. 999-97-3; Fluka Chemie AG, Buchs, Switzerland) for 10 min and air-dried in an exhaust hood at room temperature.
Processed samples were mounted on stainless steel stubs, coated with gold and stored in a desiccator until they were studied and photographed by an electron microscope on scanning mode operating at 25 kV -BS 301. A special scoring system (from 1 to 6) was introduced to analyze the morphological changes of the arterial wall of ARA under the electron microscope (Table 3) . 12 
Results
Histological analysis of the ARA arterial wall was as follows: -thawing protocol 1 (thawing at room temperature of 23°C): 6 (100%) non-coronary AV leaflets showed loss of the endothelial cells covering the basal membrane with no damage to the basal lamina (score 5) (Fig. 1) ; -thawing protocol 2 (water bath at 37°C): 5 (83%) noncoronary AV leaflets showed loss of the endothelial cells covering the basal membrane with no damage to the basal lamina (score 5); 1 (17%) non-coronary AV leaflet showed significant damage to the basal membrane (score 6) (Fig. 2) . After further investigation of the samples, it turned out that the severe damage of the non-coronary AV leaflet in thawing protocol 2 was caused by mechanical stresses exerted on the samples during dissection and microscopic sample preparation. The examined sample underwent slight stretching during microscopic slide preparation due to its size. This resulted in more severe structural damage compared to other samples. 
Discussion
Since the first successful AV allograft transplant performed by Ross in 1962, over 25000 AV allografts have been implanted to date. 13 Over the time, the procedures of sterilization and storage have evolved immensely; from fresh aseptic harvest with immediate transplantation, through antibiotic sterilization and wet storage at 4°C, up to current antibiotic sterilization and cryopreservation.
14 Even though the durability of fresh AV allografts is superior to cryopreserved AV allografts, the lack of donors has forced most of the cardiac centers to focus on allograft cryopreservation. Cryopreservation plays a major role in the degeneration of AV allografts, which subsequently leads to progressive calcification and fibrosis, affecting up to 1/4 of all implanted AV allografts. 13 Despite the negative impact of cryopreservation on AV allografts, Fukushima et al. showed that cryopreserved AV allografts were durable for over 15 years. 15 They also showed that allograft durability was closely associated with and affected by obesity and age of the recipient and donor. The most important factor was the surgical technique used during the allograft transplantation. 15 Our experimental results show identical structural changes in both examined thawing protocols; therefore, a faster rate of thawing theoretically does not necessarily mean that AV leaflets will be more structurally damaged or compromised; they would not require more frequent observation after implantation.
Another aspect that is thought to contribute to the cryopreserved AV allografts failure is gender mismatch. However, evidence behind this theory is imprecise, as gender matching is not done routinely before such transplants. Böll et al. demonstrated that gender-mismatched vs gendermatched allografts showed no significant difference in regard to death, need for reoperation and allograft function. 16 Experimental work by Brockbank et al. showed significantly reduced extracellular matrix damage and well-preserved cellular structures in ice-free leaflets. They also demonstrated that cryopreservation of the transplants of the heart valves at -80°C prevents ice formation, and tissue cracking, and preserves extracellular matrix. 8, 17 Improvements in modern antibiotic treatment of AV allografts before cryopreservation have had a significant impact on the infection resistance of AV allografts, as shown in their enhanced bacterial resistance. 18 The use of cryopreserved allografts has become a gold standard in surgical procedures, such as Ross procedure, or in cases of bacterial endocarditis. However, there is growing evidence that decellularized engineered allografts may be superior to cryopreserved allografts. 19 Decellularized AV allografts have shown outstanding mid-term results after their implantation in terms of their stable structural integrity, low rate of calcification and hemodynamic properties. 20 Despite the promising short and mid-term results, long-term results are still not known.
Even though there have been efforts to minimize the damage inflicted by cryopreservation on AV allografts, there are still many factors that need thorough experimental and clinical examination in order to ensure allografts of highest possible quality and durability.
Conclusions
Our experimental work, based in structural changes occurring during different thawing protocols in cryopreserved AV leaflets, showed that different rates of thawing indicated identical structural changes. Therefore, the rate of thawing does not play a significant role in minimizing structural changes that occur during the thawing of cryopreserved AV leaflets.
